Morrow Norman C
Commonwealth Pharmacists Association, 1 Lambeth High Street, London, SE1 7JN UK.
J Pharm Policy Pract. 2015 Feb 10;8(1):4. doi: 10.1186/s40545-015-0027-5. eCollection 2015.
Across the world medicines are the ubiquitous technology in the diagnosis, treatment and prevention of disease. Pharmaceutical policy, as part of national health care policy, is concerned with the provision and use of medicines. Pharmacists are critical to the medicines management process, yet are often largely detached from policy development. Logically, they should inform Government policies which impact on their work or where their skills could be best applied to implement health care policy and medicines utilisation in particular. It therefore makes it critically important that the pharmaceutical profession engages with national policy makers and in the strategic planning for health care. This is the first of two articles directed to this specific issue. Firstly, it identifies a number of the practice challenges for pharmacy and medicines management, their implications for policy and the need for a balanced approach. Drawing from a range of international experiences some key learning points in respect of formulating and implementing national medicines policies are presented. Finally, reference is made to several authoritative evidence bases to inform the development of pharmaceutical practice and medicines management policies.
在世界各地，药物是疾病诊断、治疗和预防中无处不在的技术。药物政策作为国家医疗保健政策的一部分，涉及药物的供应和使用。药剂师对药物管理过程至关重要，但在很大程度上往往与政策制定脱节。从逻辑上讲，他们应该为影响其工作的政府政策提供信息，或者在那些能够最好地应用其技能以实施医疗保健政策，特别是药物利用政策的领域提供信息。因此，制药行业与国家政策制定者以及医疗保健战略规划进行互动至关重要。这是针对这一特定问题的两篇文章中的第一篇。首先，它确定了药学和药物管理在实践中的一些挑战、它们对政策的影响以及采取平衡方法的必要性。借鉴一系列国际经验，介绍了制定和实施国家药物政策方面的一些关键要点。最后，参考了几个权威证据库，以为制药实践和药物管理政策的制定提供信息。
